Ghent University Academic Bibliography

Advanced

Symptomatic treatment of neurolathyrism with Tolperisone.HCL (Mydocalm): a randomized double blind and placebo controlled drug trial.

A MELKA, R TEKLE-HAIMANOT and Fernand Lambein UGent (1996) Ethiopian Medical Journal. 35. p.77-91
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle
publication status
published
subject
journal title
Ethiopian Medical Journal
volume
35
pages
77-91 pages
language
English
UGent publication?
yes
classification
A2
id
271515
handle
http://hdl.handle.net/1854/LU-271515
date created
2004-05-24 13:33:00
date last changed
2013-01-30 09:43:41
@article{271515,
  author       = {MELKA, A and TEKLE-HAIMANOT, R and Lambein, Fernand},
  journal      = {Ethiopian Medical Journal},
  language     = {eng},
  pages        = {77--91},
  title        = {Symptomatic treatment of neurolathyrism with Tolperisone.HCL (Mydocalm): a randomized double blind and placebo controlled drug trial.},
  volume       = {35},
  year         = {1996},
}

Chicago
MELKA, A, R TEKLE-HAIMANOT, and Fernand Lambein. 1996. “Symptomatic Treatment of Neurolathyrism with Tolperisone.HCL (Mydocalm): a Randomized Double Blind and Placebo Controlled Drug Trial.” Ethiopian Medical Journal 35: 77–91.
APA
MELKA, A., TEKLE-HAIMANOT, R., & Lambein, F. (1996). Symptomatic treatment of neurolathyrism with Tolperisone.HCL (Mydocalm): a randomized double blind and placebo controlled drug trial. Ethiopian Medical Journal, 35, 77–91.
Vancouver
1.
MELKA A, TEKLE-HAIMANOT R, Lambein F. Symptomatic treatment of neurolathyrism with Tolperisone.HCL (Mydocalm): a randomized double blind and placebo controlled drug trial. Ethiopian Medical Journal. 1996;35:77–91.
MLA
MELKA, A, R TEKLE-HAIMANOT, and Fernand Lambein. “Symptomatic Treatment of Neurolathyrism with Tolperisone.HCL (Mydocalm): a Randomized Double Blind and Placebo Controlled Drug Trial.” Ethiopian Medical Journal 35 (1996): 77–91. Print.